Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Sanofi

02 1GSK

03 1Pfizer Inc

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Originator

Registration Country : South Africa

Group W-135 Meningococcal Polysaccharide

Brand Name : Menactra

Dosage Form : VAC

Dosage Strength : 4ug/0.5ml

Packaging : 0.5X1ug/0.5ml

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

Sanofi Company Banner

02

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Neisseria Meningitides Purified Polysaccharides Group A, C, W135, Y

Brand Name : Mencevax ACW135Y

Dosage Form : INJ

Dosage Strength : 50ug/0.5ml

Packaging : 0.5X10ug/0.5ml

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

blank

03

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP W-135

Brand Name : NIMENRIX

Dosage Form : KIT

Dosage Strength : 5MCG/0.5ML

Packaging : 0.5ML/10X0.5ML

Approval Date :

Application Number : 2402904

Regulatory Info : Schedule D

Registration Country : Canada

blank